Detalhe da pesquisa
1.
Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma.
Mol Ther
; 31(3): 729-743, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36560881
2.
Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
Int J Cancer
; 146(1): 123-136, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31090219
3.
The Multifaceted Roles of DJ-1 as an Antioxidant.
Adv Exp Med Biol
; 1037: 67-87, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29147904
4.
Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation.
Apoptosis
; 21(12): 1422-1437, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27734217
5.
CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors.
J Exp Clin Cancer Res
; 41(1): 355, 2022 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539830
6.
Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma.
Oncotarget
; 12(9): 948-949, 2021 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33953848
7.
Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment.
Antioxidants (Basel)
; 9(3)2020 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32138149
8.
Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma.
Redox Biol
; 28: 101310, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31514052
9.
Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition.
Theranostics
; 10(12): 5259-5275, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32373211
10.
RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
Theranostics
; 10(18): 7974-7992, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32724453
11.
TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-Ðºß inhibition.
Cell Cycle
; 15(4): 559-72, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26743692
12.
Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
Redox Biol
; 8: 175-85, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26795735
13.
Expression of the thioredoxin system in an in vivo-like cancer cell environment upon auranofin treatment.
Eur J Cell Biol
; 95(10): 378-388, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27567536
14.
Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma.
Oncotarget
; 6(17): 15410-24, 2015 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25945832
15.
Cross Talk between Two Antioxidant Systems, Thioredoxin and DJ-1: Consequences for Cancer.
Oncoscience
; 1(1): 95-110, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25593990